AC AQUACELLE Trademark

Trademark Overview


On Friday, April 23, 2021, a trademark application was filed for AC AQUACELLE with the United States Patent and Trademark Office. The USPTO has given the AC AQUACELLE trademark a serial number of 79314441. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by Pharmako Biotechnologies Pty Limited. The AC AQUACELLE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary appli...
ac aquacelle

General Information


Serial Number79314441
Word MarkAC AQUACELLE
Filing DateFriday, April 23, 2021
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6897520
Registration DateTuesday, November 15, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "AC AQUACELLE".
Goods and ServicesPharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines, being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals, namely, pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents
Pseudo MarkAC AQUA CELLE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmako Biotechnologies Pty Limited
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NamePharmako Biotechnologies Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NamePharmako Biotechnologies Pty Limited
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Wednesday, March 29, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 8, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 8, 2023FINAL DISPOSITION PROCESSED
Wednesday, February 15, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, September 17, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, January 30, 2022REFUSAL PROCESSED BY IB
Thursday, January 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 13, 2022REFUSAL PROCESSED BY MPU
Wednesday, December 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 21, 2021NON-FINAL ACTION WRITTEN
Friday, December 17, 2021ASSIGNED TO EXAMINER
Saturday, July 17, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, July 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 8, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB